Senate Committee on Health, Education, Labor & Pensions

After subpoena threat, Novo CEO Jorgensen will testify at Senate

Novo Nordisk CEO Lars Fruergaard Jorgensen has agreed to face questions at a Senate hearing in September over its pricing of popular weight loss drugs

Kevin Dunleavy Jun 17, 2024 11:07am

Sanders seeks subpoena for Novo exec to answer pricing questions

Jun 12, 2024 8:01am

Sanders issues dire warning about projected GLP-1 spending

May 16, 2024 7:05am

Novo Nordisk grilled by Sanders over steep GLP-1 pricing

Apr 25, 2024 2:58pm

J&J, Merck CEOs answer Sanders' summon for pricing testimony

Jan 26, 2024 3:49pm

CEOs face possible subpoenas after rejecting Senate summons

Jan 19, 2024 9:35am